Menu

Image of the Day: Starved Worm

A heat map of gene expression provides insights on the genes that help C. elegans survive severe caloric restriction.  

Nov 14, 2017
The Scientist Staff, The Scientist Staff

A starved Caenorhabditis elegans worm in an early larval stage, showing the intensity of expression of the gene tps-1, which appears strongest in the intestine and the outer skin  JONATHAN HIBSHMAN & RYAN BAUGH / DUKE UNIVERSITY The nematode worm Caenorhabditis elegans is a popular model to study the physiological reponses that allow animals to cope with starvation. When population densities are high and food is limited, C. elegans will form specialized larval forms—so-called “dauer” larvae—that can survive for months in nutrient-poor conditions, or enter a state of developmental arrest until they feed. To explore the genetics involved in this survival adaptation, scientists took a close look at one gene, known as tps-1, that is involved in synthesizing trehalose, a sugar that helps protect the worms from desiccation and other types of stress. They found that tps-1 expression and trehalose synthesis increases during starvation periods, demonstrating its role as a stress protectant.

See J.D. Hibshman et al., “daf-16/FoxO promotes gluceogenesis and trehalose synthesis during starvation to support survival,” eLife, doi:10.7554/eLife.30057, 2017.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.